Litigation Details for Genzyme Corporation v. Fresenius Kabi USA, LLC (D. Del. 2018)
✉ Email this page to a colleague
Genzyme Corporation v. Fresenius Kabi USA, LLC (D. Del. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-12-05 |
| Court | District Court, D. Delaware | Date Terminated | 2019-04-01 |
| Cause | 35:271 Patent Infringement | Assigned To | Kent A. Jordan |
| Jury Demand | None | Referred To | |
| Patents | 6,987,102; 7,897,590 | ||
| Link to Docket | External link to docket | ||
Details for Genzyme Corporation v. Fresenius Kabi USA, LLC (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-12-05 | 1 | action for patent infringement of U.S. Patent Nos. 7,897,590 (“the ’590 patent”) and 6,987,102 (“the ’102… INFRINGEMENT BY FRESENIUS KABI OF U.S. PATENT NO. 6,987,102 54. Plaintiffs repeat and reallege…590 patent and the ’102 patent, including, but not limited to, Claims 8 and 19 of the ’590 patent and…590 patent and the ’102 patent, including, but not limited to, Claims 8 and 19 of the ’590 patent and …’102 patent. 32. Fresenius Kabi has knowledge of the ’590 patent and the ’102 patent. | External link to document | |
| 2019-02-28 | 12 | claims 8 and 19 of U.S. Patent No. 7,897,590 and claim 8 of U.S. Patent No. 6,987,102 against Defendant Fresenius…2018 1 April 2019 1:18-cv-01934 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| 2019-04-01 | 14 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,897,590 B2; US 6,987,102 B2. (nmg)…2018 1 April 2019 1:18-cv-01934 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
